Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

RKLBBullishM&Anews

High materiality7/10

Cantor Boosts RKLB on Iridium Deal and Neutron Catalyst, Sets $122 Target

Sep 22, 2026, 10:32 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Reconfirmed buy-side support (Cantor) with a lofty target; funding secured for a mid-2027 deal; Neutron catalyst provides a tangible near-term upside; multiple upgrades and a notable revenue lever from the IRDM deal can drive a re-rating from current levels.

AI summary

What happened, with direct paths to the underlying reporting

Cantor Fitzgerald reaffirmed an Overweight rating on Rocket Lab (RKLB) with a $122 target, citing Iridium's acquisition and the Neutron rocket as primary catalysts. The firm believes the deal could double annual revenue and that Neutron may become a direct alternative to SpaceX's Falcon 9 once operational. RKLB recently notched its 96th Electron launch, reinforcing its competitive momentum.

Cantor reaffirmed RKLB overweight rating and $122 target.
Iridium acquisition funding secured; closing expected mid-2027.
Neutron launch remains key catalyst, potentially rival to SpaceX Falcon 9.
96th Electron launch last weekend strengthens competitive position.
Near-term technicals improving; resistance near $78.50, support near $61.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.